SPONSOR
Shanghai Cell Therapy Group Co.,Ltd
Total Trials
3
Recruiting
3
Phases
EARLY_Phase 1
NCT06249256 EARLY_Phase 1
Recruiting
An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells
Solid Tumor
NCT06446128 EARLY_Phase 1
Recruiting
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)
Non-Hodgkin Lymphoma, B-cell
NCT06248697 EARLY_Phase 1
Recruiting
Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors
Solid Tumor